Home > Insider Trading > Filing (0001384101-21-000044)

Filing Details

Accession Number:: 0001384101-21-000044
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-08 17:33:32
Reporting Period:: 2021-03-04

Accepted Time:: 2021-03-08 17:33:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1384101	Veracyte Inc.	VCYT	Services-Medical Laboratories (8071)	205455398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769333	C Giulia Kennedy	6000 Shoreline Court Suite 300 South San Francisco CA 94080	Chief Scientific & Med Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-04	5,313	$9.05	80,082	No	4	M	Direct
Common Stock	Acquisiton	2021-03-04	4,407	$5.98	84,489	No	4	M	Direct
Common Stock	Acquisiton	2021-03-04	3,750	$20.21	88,239	No	4	M	Direct
Common Stock	Acquisiton	2021-03-04	17,500	$24.69	105,739	No	4	M	Direct
Common Stock	Disposition	2021-03-04	20,239	$47.11	85,500	No	4	S	Direct
Common Stock	Disposition	2021-03-04	8,483	$48.29	77,017	No	4	S	Direct
Common Stock	Disposition	2021-03-04	2,991	$49.22	74,026	No	4	S	Direct
Common Stock	Disposition	2021-03-04	2,819	$50.40	71,207	No	4	S	Direct
Common Stock	Disposition	2021-03-04	8,114	$51.38	63,093	No	4	S	Direct
Common Stock	Disposition	2021-03-04	5,032	$52.38	58,061	No	4	S	Direct
Common Stock	Disposition	2021-03-04	2,606	$53.50	55,455	No	4	S	Direct
Common Stock	Disposition	2021-03-04	1,431	$54.72	54,024	No	4	S	Direct
Common Stock	Disposition	2021-03-04	300	$55.49	53,724	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-03-04	5,313	$0.00	5,313	$9.05
Common Stock	Stock Option (right to buy)	Disposition	2021-03-04	4,407	$0.00	4,407	$5.98
Common Stock	Stock Option (right to buy)	Disposition	2021-03-04	3,750	$0.00	3,750	$20.21
Common Stock	Stock Option (right to buy)	Disposition	2021-03-04	17,500	$0.00	17,500	$24.69

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2027-03-02	No	4	M	Direct
17,625	2028-03-01	No	4	M	Direct
30,000	2029-02-27	No	4	M	Direct
52,500	2030-03-27	No	4	M	Direct

Footnotes

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.
Represents weighted average sales price. Sale prices for the transactions range from $46.78 to $47.78. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $47.80 to $48.80. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $48.82 to $49.81. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $49.87 to $50.87. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $50.90 to $51.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $51.94 to $52.93. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $52.99 to $53.99. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $54.11 to $55.10. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $55.31 to $55.67. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
The option is fully vested.
The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.